Recurrent Mature B-cell Neoplasms
1 clinical trials · Condition
◉ Watch Recurrent Mature B-cell Neoplasms
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms (NCT01704963) | Janssen Pharmaceutical K.K. | 2012-09-12 |
Track Recurrent Mature B-cell Neoplasms automatically
Every clearance here is in the API, with alerts when new ones post.